Pseudohypoxia: Difference between revisions

From WikiMD's Wellness Encyclopedia

CSV import
Tag: Reverted
No edit summary
Tag: Manual revert
 
Line 19: Line 19:
{{disease-stub}}
{{disease-stub}}
{{No image}}
{{No image}}
__NOINDEX__

Latest revision as of 17:17, 22 March 2025

Pseudohypoxia refers to increased cytosolic ratio of free NAD to NADH in cells, caused by hyperglycemia.<ref name=a>[1] Diabetes Magazine: Hyperglycemic Pseudohypoxia and Diabetic Complications, March 12, 1993</ref> Research has shown that declining levels of NAD+ during aging cause pseudohypoxia, and that raising nuclear NAD+ in old mice reverses pseudohypoxia and metabolic dysfunction, thus reversing the aging process.<ref>[2] Declining NAD+ Induces a Pseudohypoxic State Disrupting Nuclear-Mitochondrial Communication during Aging, Cell, Dec 2013</ref> It is expected that human NAD trials will begin in 2014.<ref>[3] Guardian Newspaper - Online, Dec 2013</ref>

Pseudohypoxia is a feature commonly noted in poorly-controlled diabetes.<ref name= a/>

See also[edit]

References[edit]

<references group="" responsive="1"></references>


Stub icon
   This article is a  stub. You can help WikiMD by expanding it!